GMAX Biopharm
Innovative antibody development for chronic kidney disease, obesity, and diabetes treatment. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€284—425m (Dealroom.co estimates Mar 2021.)
Hangzhou Zhejiang (HQ)
Authorizing premium user...